SwanBio Therapeutics Announces Series A Expansion
SwanBio Therapeutics Announces Series A Expansion to Fund its Lead Program and Grow Pipeline in Gene Therapy for Neurological Diseases $52 million is being allocated to progress IND-enabling studies in…